Surprisingly, these microRNAs boost—rather than dampen—protein expression

Surprisingly, these microRNAs boost—rather than dampen—protein expression
Graphical abstract. Credit: ACS Central Science (2022). DOI: 10.1021/acscentsci.2c00748

MicroRNAs can play a role in cancer development and are thought to exclusively suppress protein expression in dividing cells, such as tumor cells. But new research published in ACS Central Science shows that some of these tiny molecules can elevate the expression of a particular gene in dividing human cells and in cancer cells, challenging conventional wisdom.

Only a few nucleotides in length, microRNAs, or miRNAs for short, don't encode proteins. Instead, they largely downregulate, or suppress, protein production by silencing the expression of certain genes.

One class of cellular machinery regulated by miRNAs are the enzymes involved in mediating glycosylation, which add carbohydrates to certain proteins. In , however, this process can be highly dysregulated, suggesting that miRNAs could be doing something unusual. So, Lara Mahal and colleagues set out to investigate exactly how miRNAs function within the glycosylation process, and whether the molecules might be functioning in a new way.

Previously, in ACS Chemical Biology, the researchers developed a fluorescence assay that can analyze how miRNAs interact with their targets, and whether they increase or decrease the amount of protein produced. They used the assay to investigate the regulation of cancer-related glycosylation enzymes ST6GAL1 and ST6GAL2, and found that for the former, the miRNAs appeared to directly upregulate the process in noncancerous .

This challenges the current understanding that miRNAs only downregulate protein production. They also tested for miRNA-mediated upregulation in multiple cancer cell lines and observed the same results. The researchers say that this work expands the understanding of how miRNAs work, an important consideration for using miRNA-based therapeutics in both current and future clinical trials.

More information: Faezeh Jame-Chenarboo et al, High-Throughput Analysis Reveals miRNA Upregulating α-2,6-Sialic Acid through Direct miRNA–mRNA Interactions, ACS Central Science (2022). DOI: 10.1021/acscentsci.2c00748

Chu T. Thu et al, High-Throughput miRFluR Platform Identifies miRNA Regulating B3GLCT That Predict Peters' Plus Syndrome Phenotype, Supporting the miRNA Proxy Hypothesis, ACS Chemical Biology (2021). DOI: 10.1021/acschembio.1c00247

Citation: Surprisingly, these microRNAs boost—rather than dampen—protein expression (2022, November 9) retrieved 29 November 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Mechanisms, therapeutic targets of microRNA-associated chemoresistance in epithelial ovarian cancer


Feedback to editors